Douglas Swirsky - GenVec President CEO, Director
CEO
Mr. Douglas J. Swirsky is President, Chief Executive Officer, Corporationrationrate Secretary, Director of GenVec, Inc. He joined GenVec in 2006 as Chief Financial Officer, Treasurer, and Corporationrationrate Secretary and continues to serve as Corporationrationrate Secretary. Prior to joining GenVec, Mr. Swirsky was a Managing Director and the Head of Life Sciences Investment Banking at Stifel Nicolaus from 2005 to 2006 and held investment banking positions at Legg Mason from 2002 until Stifel Financials acquisition of the Legg Mason Capital Markets business in 2005. Mr. Swirsky, a Certified Public Accountant and a holder of a Chartered Financial Analyst designation, has also previously held investment banking positions at UBS, PaineWebber, and Morgan Stanley. His experience also includes positions in public accounting and consulting. Mr. Swirsky received his B.S. in Business Administration from Boston University and his M.B.A. from the Kellogg School of Management at Northwestern University. Mr. Swirsky is a member of the Board of Directors of Fibrocell Science, Inc. Within the past five years, Mr. Swirsky has also served on the board of PolyMedix, Inc. since 2014.
| Age | 44 |
| Tenure | 10 years |
| Phone | 240-632-0740 |
| Web | http://www.genvec.com |
GenVec Management Efficiency
The company has return on total asset (ROA) of (86.26) % which means that it has lost $86.26 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (248.11) %, meaning that it created substantial loss on money invested by shareholders. GenVec's management efficiency ratios could be used to measure how well GenVec manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 7 records | CEO Age | ||
| Mark Parker | Nike Inc | 68 | |
| John II | Nike Inc | 63 | |
| Louis Pinkham | RBC Bearings Incorporated | 48 | |
| W Kelly | JBG SMITH Properties | 48 | |
| Charles Bergh | Levi Strauss Co | 66 | |
| Matthew Kelly | JBG SMITH Properties | 51 | |
| John Donahoe | Nike Inc | 60 | |
Management Performance
| Return On Equity | -248.11 | |||
| Return On Asset | -86.26 |
GenVec Inc Leadership Team
Elected by the shareholders, the GenVec's board of directors comprises two types of representatives: GenVec inside directors who are chosen from within the company, and outside directors, selected externally and held independent of GenVec. The board's role is to monitor GenVec's management team and ensure that shareholders' interests are well served. GenVec's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, GenVec's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Douglas Swirsky, President CEO, Director | ||
| Stefan Loren, Director | ||
| Wayne Hockmeyer, Chairman of the Board | ||
| Quinterol Mallette, Director | ||
| Douglas Brough, Chief Scientific Officer | ||
| William Kelley, Independent Director | ||
| Marc Schneebaum, Independent Director | ||
| Michael Richman, Director | ||
| Rena Cohen, IR Contact Officer | ||
| Bryan Butman, Sr. VP of Devel. | ||
| James Lambert, Sr. Director of Accounting and Fin., Treasurer and Corporate Controller |
GenVec Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is GenVec a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -248.11 | |||
| Return On Asset | -86.26 | |||
| Current Valuation | 25.09 M | |||
| Shares Outstanding | 2.27 M | |||
| Shares Owned By Insiders | 3.97 % | |||
| Shares Owned By Institutions | 32.70 % | |||
| Number Of Shares Shorted | 250.07 K | |||
| Price To Earning | (1.94) X | |||
| Price To Book | 26.25 X | |||
| Price To Sales | 48.80 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Consideration for investing in GenVec Stock
If you are still planning to invest in GenVec Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the GenVec's history and understand the potential risks before investing.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |